M2C
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
    1.3903    2.4584   -1.6550 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5823    2.8926   -0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7654    2.4987   -0.8093 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0341    2.3065    0.8254 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4412    0.9001    1.0883 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4424   -0.1091   -0.0651 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9201   -1.1654   -0.2740 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2926   -0.0031   -0.4876 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6463    3.1250    2.0163 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6784    4.4152   -0.5728 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9019    5.0272   -0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9764    6.4130   -0.8194 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8358    7.1393   -0.5128 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3375    6.4587   -0.2324 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4430    5.1110   -0.2372 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2 10  1  0
  4  9  1  1
  4  5  1  0
  4  2  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB01882

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02085

>  <COMMON_NAME>  (1) 
(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol

$$$$
